Filing Details
- Accession Number:
- 0001127602-23-007983
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-01 17:40:18
- Reporting Period:
- 2023-02-28
- Accepted Time:
- 2023-03-01 17:40:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1665678 | Charles Alpuche | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Advisor | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-28 | 335 | $276.36 | 45,584 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-02-28 | 4,000 | $31.21 | 49,584 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-28 | 3,800 | $278.81 | 45,784 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-28 | 200 | $279.01 | 45,584 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2023-02-28 | 4,000 | $0.00 | 4,000 | $31.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,748 | 2026-02-03 | No | 4 | M | Direct |
Footnotes
- This transaction represents the withholding of shares upon the vesting of restricted stock units to cover the associated tax obligations.
- This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
Billionaire Hedge Funds
